Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0HD2 stock hub

LON/0HD2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HD2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

28.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HD2

In the news

Latest news · LON/0HD2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.7

P25 12.9P50 16.9P75 23.5

Trailing P/E71

P25 15.9P50 22.9P75 35.8

ROE90.4

P25 -54.2P50 2.1P75 13.7

ROIC78.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HD2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

USD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	2,500
Employees Change	270%
Employees Change Percent	12.11
Enterprise value	$28.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US02043Q1076
Last refreshed	2026-05-10
Market cap	$28.9B
Price	$296
Price currency	USD
Rev Per Employee	1,298,603.29x
Sector	Healthcare
Sic	2836
Symbol	lon/0HD2
Website	https://www.alnylam.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.41%
EV Earnings	70.89x
EV/EBIT	52.32x
EV/EBITDA	44.54x
EV/FCF	59.28x
EV/Sales	9.18x
FCF yield	1.69%
Forward P/E	27.73x
P/B ratio	35.5x
P/E ratio	70.96x
P/S ratio	8.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.54%
EBITDA Margin	18.82%
FCF margin	15.01%
Gross margin	80.83%
Gross Profit	$2.6B
Gross Profit Growth	71.56%
Gross Profit Growth Q	82.75%
Gross Profit Growth3 Y	53.64%
Gross Profit Growth5 Y	48.79%
Net Income	$407.4M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Pretax Margin	12.76%
Profit Margin	12.55%
Profit Per Employee	$162,969
Profitable Years	1
ROA	10.06
Roa5y	-5.39
ROCE	19.9
ROE	90.36
ROIC	78.43
Roic5y	-149.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	7.71%
Cagr3y	11.89%
Cagr5y	17.66%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth	82.57x
Revenue Growth Q	96.43x
Revenue Growth Quarters	6x
Revenue Growth Years	7x
Revenue Growth3 Y	55.35x
Revenue Growth5 Y	49.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.92
Assets	$3.9B
Cash	$2.3B
Current Assets	$3.1B
Current Liabilities	$989.9M
Debt	$2.2B
Debt EBITDA	$3.36
Debt Equity	$2.76
Debt FCF	$4.62
Equity	$814.4M
Interest Coverage	2.85
Liabilities	$3.1B
Long Term Assets	$789.7M
Long Term Liabilities	$2.1B
Net Cash	$29.5M
Net Cash By Market Cap	$0.1
Net Debt EBITDA	$-0.05
Net Debt Equity	$-0.04
Net Debt FCF	$-0.06
Tangible Book Value	$814.4M
Tangible Book Value Per Share	$6.1
WACC	6.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.13
Inventory Turnover	10.99
Net Working Capital	$101.3M
Quick ratio	2.88
Working Capital	$2.2B
Working Capital Turnover	$1.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	7.7%
200-day SMA	391.9
3Y total return	40.1%
50-day SMA	316.4
50-day SMA vs 200-day SMA	50under200
5Y total return	125.43%
All Time High	500.2
All Time High Change	-40.9%
All Time High Date	2025-10-30
All Time Low	65
All Time Low Change	354.84%
All Time Low Date	2018-11-15
ATR	13.93
Beta	0.3
Ch YTD	-26.5
High	303
High52	500.2
High52 Date	2025-10-30
High52ch	-40.9%
Low	291.5
Low52	246.3
Low52 Date	2025-05-08
Low52ch	20.02%
Ma50ch	-6.57%
Price vs 200-day SMA	-24.57%
RSI	40.6
RSI Monthly	47.64
RSI Weekly	33.38
Sharpe ratio	0.33x
Sortino ratio	0.64
Total Return	-6.45%
Tr YTD	-26.5
Tr1m	-8.18%
Tr1w	-1.77%
Tr3m	-10.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$569.6M
Operating Income Growth Q	1,386.1
Operating margin	17.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	132,960,706%
Net Borrowing	-401,192,548.2
Shares Insiders	0.37%
Shares Institutions	97%
Shares Qo Q	1.43%
Shares Yo Y	6.45%
Short Ratio	4.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$213.3M
Average Volume	504.95x
Bv Per Share	6.1
CAPEX	$-54.2M
Ch1m	-8.18
Ch1w	-1.77
Ch1y	7.7
Ch3m	-10.68
Ch3y	40.1
Ch5y	125.4
Ch6m	-32.12
Change	0%
Change From Open	0.02
Close	295.6
Days Gap	-0.02
Depreciation Amortization	40,200,968.3
Dollar Volume	21,877.7
Earnings Date	2026-04-30
EBIT	$569.6M
EBITDA	$611.1M
EPS	$2.99
F Score	6
FCF	$487.2M
FCF EV Yield	1.69x
Financing CF	-254,119,751
Fiscal Year End	December
Founded	2,002
Graham Number	27.9419
Graham Upside	-90.55
Income Tax	$7M
Investing CF	224,933,216
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Ma150	378.9
Ma150ch	-21.98%
Ma20	309.4
Ma20ch	-4.44%
Net CF	522,669,192
Next Earnings Date	2026-08-06
Open	295.6
P FCF Ratio	59.34
P OCF Ratio	53.4
Position In Range	35.92
Ppne	519,002,231.8
Price Date	2026-05-08
Price EBITDA	$47.31
Ptbv Ratio	35.5
Relative Volume	0.14x
Revenue	3,246,508,223x
SBC By Revenue	8.44x
Share Based Comp	273,899,800
Tax By Revenue	0.21x
Tax Rate	1.68%
Tr6m	-32.12%
Volume	74
Z Score	7.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HD2 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HD2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HD2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+97.0%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HD2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.6

Neutral momentum band

Price vs 200-day MA

-24.6%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HD2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HD2 stock rating?

lon/0HD2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HD2 analysis?

The full report lives at /stocks/lon/0HD2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HD2?

The latest report frames lon/0HD2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HD2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.